Skip to main content
. 2013 Dec 4;306(3):F359–F366. doi: 10.1152/ajprenal.00330.2013

Fig. 5.

Fig. 5.

Summary of immunoblots from cortex of control and tolvaptan-treated rats. Values are normalized band densities (means ± SE). Tolvaptan (2.5 mg/day) or vehicle was infused for 4 days; n = 5 for both control and tolvaptan groups. *Statistical significance (P < 0.05, t-test).